Becton Dickinson and Co
NYSE:BDX
Becton Dickinson and Co
NYSE:BDX
Price:
240.35 USD
2.84%
Market Closed
Updated:
May 3, 2024
Becton Dickinson and Co
Operating Income
|
Becton Dickinson and Co
Operating Income Peer Comparison
Comparables:
BSX
EW
SYK
ABT
ISRG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Operating Income
$1.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Becton Dickinson and Co's Operating Income?
Operating Income
2.1B
USD
2.1B
USD
Based on the financial report for Dec 31, 2023, Becton Dickinson and Co's Operating Income amounts to 2.1B USD.
What is Becton Dickinson and Co's Operating Income growth rate?
Operating Income CAGR 10Y
5%
5%
Over the last year, the Operating Income growth was -15%. The average annual Operating Income growth rates for Becton Dickinson and Co have been 1% over the past three years , -5% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
